DR. REDDYS LABORATORIES, INC — Fluoxetine Importer Profile
Pharmaceutical Importer · #10 buyer for Fluoxetine · $1.4M import value · 52 shipments · UNITED STATES · DGFT Verified
DR. REDDYS LABORATORIES, INC is the #10 importer of Fluoxetine from India with $1.4M in import value and 52 verified shipments. DR. REDDYS LABORATORIES, INC holds a 1.4% market share in Fluoxetine imports based in UNITED STATES. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, DR. REDDYS LABORATORIES, INC imports 6 pharmaceutical products worth $9.1M across 5 therapeutic categories.
DR. REDDYS LABORATORIES, INC — Fluoxetine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Fluoxetine to DR. REDDYS LABORATORIES, INC?
Verified from 52 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $1.4M | 52 | 100.0% |
DR. REDDYS LABORATORIES, INC sources Fluoxetine from 1 verified Indian supplier based on 52 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 100.0% of imports.
How Does DR. REDDYS LABORATORIES, INC Compare to Nearest Fluoxetine Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | TIME-CAP LABS, | UNITED STATES | $2.7M | 62 | $43.0K |
| 9 | J. KNIPPER & COMPANY | UNITED STATES | $2.6M | 117 | $21.9K |
| 10 | DR. REDDYS LABORATORIES, INC ★ | UNITED STATES | $2.3M | 45 | $50.0K |
| 11 | MEDREICH PLC | UNITED KINGDOM | $2.2M | 125 | $17.5K |
| 12 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $2.1M | 86 | $24.4K |
DR. REDDYS LABORATORIES, INC ranks #10 among 522 Fluoxetine importers from India. Average shipment value of $50.0K compared to the market average of $41.4K. The closest competitors by value are TIME-CAP LABS, and J. KNIPPER & COMPANY.
Where Does DR. REDDYS LABORATORIES, INC Import Fluoxetine To?
Destination countries from 52 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.4M | 52 | 100.0% |
DR. REDDYS LABORATORIES, INC imports Fluoxetine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.4M.
What Fluoxetine Formulations Does DR. REDDYS LABORATORIES, INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| FLUOXETINE TABLETS USP 20MG 100S (TOTAL | $443.0K | 13 |
| FLUOXETINE TABLETS USP 60MG 30S (TOTAL | $107.6K | 3 |
| FLUOXETINE TABLETS USP 10MG (27144 X 30S | $83.2K | 6 |
| FLUOXETINE TABLETS USP 20MG 100S (TOTALQTY PACKS 42864 X 100S=4286400 NOS) | $72.2K | 3 |
| FLUOXETINE TABLETS USP 10MG 100S USA (T | $64.9K | 2 |
| FLUOXETINE TABLETS USP 10MG 30S (TOTAL | $58.8K | 2 |
| FLUOXETINE TABLETS USP 10MG 30S (TOTAL Q | $50.9K | 2 |
| FLUOXETINE DELAYED-RELEASE CAPSULES USP | $50.0K | 1 |
| FLUOXETINE TABLETS USP 60MG 30S (TOTALQTY PACKS 44856 X 30S=1345680 NOS) | $50.0K | 1 |
| FLUOXETINE DELAYED RELEASE CAPSULES USP90MG 4S (TOTAL QTY PACKS 12708 X 4S=50832 NOS) | $50.0K | 1 |
DR. REDDYS LABORATORIES, INC imports 22 distinct Fluoxetine formulations from India. The top formulation is FLUOXETINE TABLETS USP 20MG 100S (TOTAL with 13 shipments worth $443.0K.
Regulatory Requirements: Importing Fluoxetine into United States
What DR. REDDYS LABORATORIES, INC and other importers must comply with to import Fluoxetine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Fluoxetine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Fluoxetine from India and How Much Does DR. REDDYS LABORATORIES, INC Import?
India exported $21.6M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. DR. REDDYS LABORATORIES, INC imports $1.4M of this total, accounting for 1.4% of India's Fluoxetine exports with 52 shipments from UNITED STATES. This is verified from 52 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for DR. REDDYS LABORATORIES, INC's Fluoxetine Imports?
DR. REDDYS LABORATORIES, INC's average Fluoxetine order value is $26.2K per consignment, based on 52 shipments totaling $1.4M. DR. REDDYS LABORATORIES, INC is based in UNITED STATES and ranks #10 among all Fluoxetine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Fluoxetine to DR. REDDYS LABORATORIES, INC?
DR. REDDYS LABORATORIES, INC sources Fluoxetine from 1 verified Indian supplier: DR.REDDY'S LABORATORIES LIMITED ($1.4M, 100.0%). This is based on 52 customs records.
How Does DR. REDDYS LABORATORIES, INC Compare to Other Fluoxetine Importers?
DR. REDDYS LABORATORIES, INC ranks #10 among 522 Fluoxetine importers from India with a 1.4% market share. The top 3 importers are TIME-CAP LABS, ($2.7M), J. KNIPPER & COMPANY ($2.6M), DR. REDDYS LABORATORIES, INC ($2.3M). DR. REDDYS LABORATORIES, INC processed 52 shipments from UNITED STATES.
About DR. REDDYS LABORATORIES, INC
DR. REDDYS LABORATORIES, INC imports 6 products worth $9.1M. Beyond Fluoxetine, top products include Metoprolol, Clopidogrel, Doxorubicin, Ciprofloxacin, Dexamethasone. View the complete DR. REDDYS LABORATORIES, INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DR. REDDYS LABORATORIES, INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DR. REDDYS LABORATORIES, INC's capped import value divided by total capped export value for Fluoxetine across all Indian exporters.
- 5.Verified Records: This page is backed by 52 individual customs records matching DR. REDDYS LABORATORIES, INC importing Fluoxetine, covering 22 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Import Data for DR. REDDYS LABORATORIES, INC
Access order-level details, pricing data, supplier connections, and competitive analysis for DR. REDDYS LABORATORIES, INC's Fluoxetine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR. REDDYS LABORATORIES, INC
Full Company Profile →
6 products · $9.1M total trade · 5 categories
DR. REDDYS LABORATORIES, INC × Fluoxetine
Verified from customs records
Company Overview
Top Products by DR. REDDYS LABORATORIES, INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DR. REDDYS LABORATORIES, INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current order-level data, contact TransData Nexus.